Advanced search
Publication Cover
Drug Metabolism Reviews Volume 42, 2010 - Issue 3: Special Issue: Transporter-drug interactions and transporter-mediated toxicity in the liver/hepatocyte
Submit an article Journal homepage
559
Views
53
CrossRef citations to date
0
Altmetric
Review Article

Regulation of hepatic ABCC transporters by xenobiotics and in disease states

Xinsheng GuDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, USA
&
Jose E. ManautouDepartment of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut, USACorrespondence[email protected]
Pages 482-538 | Published online: 16 Mar 2010

References

  • Achira, M., Totsuka, R., Fujimura, H., Kume, T. (2002). Decreased hepatobiliary transport of methotrexate in adjuvant arthritis rats. Xenobiotica 32:1151–1160.
  • Adachi, T., Nakagawa, H., Chung, I., Hagiya, Y., Hoshijima, K., Noguchi, N., et al. (2007). Nrf2-dependent and -independent induction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. J Exp Ther Oncol 6:335–348.
  • Aleksandrov, A. A., Aleksandrov, L. A., Riordan, J. R. (2007). CFTR (ABCC7) is a hydrolyzable-ligand-gated channel. Pflugers Arch 453:693–702.
  • Aleksunes, L. M., Augustine, L. M., Cherrington, N. J., Manautou, J. E. (2007). Influence of acetaminophen vehicle on regulation of transporter gene expression during hepatotoxicity. J Toxicol Environ Health A 70:1870–1872.
  • Aleksunes, L. M., Campion, S. N., Goedken, M. J., Manautou, J. E. (2008a). Acquired resistance to acetaminophen hepatotoxicity is associated with induction of multidrug resistance-associated protein 4 (Mrp4) in proliferating hepatocytes. Toxicol Sci 104:261–273.
  • Aleksunes, L. M., Scheffer, G. L., Jakowski, A. B., Pruimboom-Brees, I. M., Manautou, J. E. (2006). Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury. Toxicol Sci 89:370–379.
  • Aleksunes, L. M., Slitt, A. L., Maher, J. M., Augustine, L. M., Goedken, M. J., Chan, J. Y., et al. (2008b). Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2. Toxicol Appl Pharmacol 226:74–83.
  • Aleksunes, L. M., Slitt, A. M., Cherrington, N. J., Thibodeau, M. S., Klaassen, C. D., Manautou, J. E. (2005). Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride. Toxicol Sci 83:44–52.
  • Ameen, N., Silvis, M., Bradbury, N. A. (2007). Endocytic trafficking of CFTR in health and disease. J Cyst Fibros 6:1–14.
  • Anapolsky, A., Teng, S., Dixit, S., Piquette-Miller, M. (2006). The role of pregnane X receptor in 2-acetylaminofluorene-mediated induction of drug transport and -metabolizing enzymes in mice. Drug Metab Dispos 34:405–409.
  • Annilo, T., Dean, M. (2004). Degeneration of an ATP-binding cassette transporter gene, ABCC13, in different mammalian lineages. Genomics 84:34–46.
  • Aoki, K., Nakajima, M., Hoshi, Y., Saso, N., Kato, S., Sugiyama, Y., et al. (2008a). Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors. Biol Pharm Bull 31:412–420.
  • Aoki, K., Saso, N., Kato, S., Sugiyama, Y., Sato, H. (2008b). Nitric oxide and peroxynitrite regulate transporter transcription in rat liver slices. Biol Pharm Bull 31:1882–1887.
  • Aranyi, T., Ratajewski, M., Bardoczy, V., Pulaski, L., Bors, A., Tordai, A., et al. (2005). Identification of a DNA methylation-dependent activator sequence in the pseudoxanthoma elasticum gene, ABCC6. J Biol Chem 280:18643–18650.
  • Asamoto, Y., Tazuma, S., Ochi, H., Chayama, K., Suzuki, H. (2001). Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity, and transporter expression and function. Biochem J 359:605–610.
  • Ashfield, R., Ashcroft, S. J. (1998). Cloning of the promoters for the beta-cell ATP-sensitive K-channel subunits Kir6.2 and SUR1. Diabetes 47:1274–1280.
  • Assem, M., Schuetz, E. G., Leggas, M., Sun, D., Yasuda, K., Reid, G., et al. (2004). Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem 279:22250–22257.
  • Bakos, E., Homolya, L. (2007). Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1). Pflugers Arch 453:621–641.
  • Ballatori, N., Fang, F., Christian, W. V., Li, N., Hammond, C. L. (2008). Ostalpha-Ostbeta is required for bile acid and conjugated steroid disposition in the intestine, kidney, and liver. Am J Physiol Gastrointest Liver Physiol 295:G179–G186.
  • Barnes, S. N., Aleksunes, L. M., Augustine, L., Scheffer, G. L., Goedken, M. J., Jakowski, A. B., et al. (2007). Induction of hepatobiliary efflux transporters in acetaminophen-induced acute liver failure cases. Drug Metab Dispos 35:1963–1969.
  • Beilke, L. D., Besselsen, D. G., Cheng, Q., Kulkarni, S., Slitt, A. L., Cherrington, N. J. (2008). Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis. Toxicol Sci 102:196–204.
  • Belinsky, M. G., Kruh, G. D. (1999). MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver. Br J Cancer 80:1342–1349.
  • Bera, T. K., Lee, S., Salvatore, G., Lee, B., Pastan, I. (2001). MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol Med 7:509–516.
  • Bergen, A. A., Plomp, A. S., Hu, X., de Jong, P. T., Gorgels, T. G. (2007). ABCC6 and pseudoxanthoma elasticum. Pflugers Arch 453:685–691.
  • Bodo, A., Bakos, E., Szeri, F., Varadi, A., Sarkadi, B. (2003). The role of multidrug transporters in drug availability, metabolism, and toxicity. Toxicol Lett 140–141:133–143.
  • Bohan, A., Chen, W. S., Denson, L. A., Held, M. A., Boyer, J. L. (2003). Tumor necrosis factor alpha-dependent upregulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J Biol Chem 278:36688–36698.
  • Bonin, S., Pascolo, L., Croce, L. S., Stanta, G., Tiribelli, C. (2002). Gene expression of ABC proteins in hepatocellular carcinoma, perineoplastic tissue, and liver diseases. Mol Med 8:318–325.
  • Borst, P., de Wolf, C., van de Wetering, K. (2007). Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch 453:661–673.
  • Borst, P., Elferink, R. O. (2002). Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537–592.
  • Borst, P., Evers, R., Kool, M., Wijnholds, J. (2000). A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst 92:1295–1302.
  • Borst, P., Zelcer, N., van de Wetering, K. (2006). MRP2 and 3 in health and disease. Cancer Lett 234:51–61.
  • Bramow, S., Ott, P., Thomsen Nielsen, F., Bangert, K., Tygstrup, N., Dalhoff, K. (2001). Cholestasis and regulation of genes related to drug metabolism and biliary transport in rat liver following treatment with cyclosporine A and sirolimus (Rapamycin). Pharmacol Toxicol 89:133–139.
  • Bremer, S., Hoof, T., Wilke, M., Busche, R., Scholte, B., Riordan, J. R., et al. (1992). Quantitative expression patterns of multidrug-resistance P-glycoprotein (MDR1) and differentially spliced cystic-fibrosis transmembrane-conductance regulator mRNA transcripts in human epithelia. Eur J Biochem 206:137–149.
  • Briz, O., Cassio, D., Blazquez, A. G., Grosse, B., Serrano, M. A., Marin, J. J. (2007). Characterization of WIF-B9/R cells as an in vitro model with hepatocyte-like polarity and enhanced expression of canalicular ABC transporters involved in phase III of hepatic detoxification. Toxicology 232:24–36.
  • Bryan, J., Munoz, A., Zhang, X., Dufer, M., Drews, G., Krippeit-Drews, P., et al. (2007). ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Pflugers Arch 453:703–718.
  • Busch, W., Saier, M. H., Jr. (2002). The transporter classification (TC) system, 2002. Crit Rev Biochem Mol Biol 37:287–337.
  • Cai, S. Y., Gautam, S., Nguyen, T., Soroka, C. J., Rahner, C., Boyer, J. L. (2009). ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. Gastroenterology 136:1060–1069.
  • Campion, S. N., Johnson, R., Aleksunes, L. M., Goedken, M. J., van Rooijen, N., Scheffer, G. L., et al. (2008). Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function. Am J Physiol Gastrointest Liver Physiol 295:G294–G304.
  • Campion, S. N., Tatis-Rios, C., Augustine, L. M., Goedken, M. J., van Rooijen, N., Cherrington, N. J., et al. (2009). Effect of allyl alcohol on hepatic transporter expression: zonal patterns of expression and role of Kupffer cell function. Toxicol Appl Pharmacol 236:49–58.
  • Cao, J., Huang, L., Liu, Y., Hoffman, T., Stieger, B., Meier, P. J., et al. (2001). Differential regulation of hepatic bile salt and organic anion transporters in pregnant and postpartum rats and the role of prolactin. Hepatology 33:140–147.
  • Cao, J., Stieger, B., Meier, P. J., Vore, M. (2002). Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. Am J Physiol Gastrointest Liver Physiol 283:G757–G766.
  • Cassio, D., Macias, R. I., Grosse, B., Marin, J. J., Monte, M. J. (2007). Expression, localization, and inducibility by bile acids of hepatobiliary transporters in the new polarized rat hepatic cell lines, Can 3-1 and Can 10. Cell Tissue Res 330:447–460.
  • Cekic, D., Bellarosa, C., Garcia-Mediavilla, M. V., Rigato, I., Pascolo, L., Ostrow, J. D., et al. (2003). Upregulation in the expression of multidrug resistance protein Mrp1 mRNA and protein by increased bilirubin production in rat. Biochem Biophys Res Commun 311:891–896.
  • Chandra, P., Johnson, B. M., Zhang, P., Pollack, G. M., Brouwer, K. L. (2005a). Modulation of hepatic canalicular or basolateral transport proteins alters hepatobiliary disposition of a model organic anion in the isolated perfused rat liver. Drug Metab Dispos 33:1238–1243.
  • Chandra, P., Zhang, P., Brouwer, K. L. (2005b). Short-term regulation of multidrug resistance-associated protein 3 in rat and human hepatocytes. Am J Physiol Gastrointest Liver Physiol 288:G1252–G1258.
  • Chang, T. H., Hakamada, K., Toyoki, Y., Tsuchida, S., Sasaki, M. (2004). Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats. Transplantation 77:22–27.
  • Chen, C., Klaassen, C. D. (2004). Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility. Biochem Biophys Res Commun 317:46–53.
  • Chen, H. L., Chen, H. L., Liu, Y. J., Feng, C. H., Wu, C. Y., Shyu, M. K., et al. (2005). Developmental expression of canalicular transporter genes in human liver. J Hepatol 43:472–477.
  • Chen, H. L., Liu, Y. J., Chen, H. L., Wu, S. H., Ni, Y. H., Ho, M. C., et al. (2008). Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia. Pediatr Res 63:667–673.
  • Chen, W., Cai, S. Y., Xu, S., Denson, L. A., Soroka, C. J., Boyer, J. L. (2007). Nuclear receptors RXRalpha:RARalpha are repressors for human MRP3 expression. Am J Physiol Gastrointest Liver Physiol 292:G1221–G1227.
  • Cheng, Q., Aleksunes, L. M., Manautou, J. E., Cherrington, N. J., Scheffer, G. L., Yamasaki, H., et al. (2008). Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity. Mol Pharm 5:77–91.
  • Cheng, X., Klaassen, C. D. (2006). Regulation of mRNA expression of xenobiotic transporters by the pregnane X receptor in mouse liver, kidney, and intestine. Drug Metab Dispos 34:1863–1867.
  • Cherrington, N. J., Hartley, D. P., Li, N., Johnson, D. R., Klaassen, C. D. (2002). Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J Pharmacol Exp Ther 300:97–104.
  • Cherrington, N. J., Slitt, A. L., Li, N., Klaassen, C. D. (2004). Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats. Drug Metab Dispos 32:734–741.
  • Cherrington, N. J., Slitt, A. L., Maher, J. M., Zhang, X. X., Zhang, J., Huang, W., et al. (2003). Induction of multidrug resistance protein 3 (mrp3) in vivo is independent of constitutive androstane receptor. Drug Metab Dispos 31:1315–1319.
  • Chiba, M., Itagaki, S., Kobayashi, M., Hirano, T., Iseki, K. (2007). Characterization of hepatobiliary organic anion transporters in Long-Evans Cinnamon rats. Drug Metab Pharmacokinet 22:387–390.
  • Chu, X. Y., Strauss, J. R., Mariano, M. A., Li, J., Newton, D. J., Cai, X., et al. (2006). Characterization of mice lacking the multidrug resistance protein MRP2 (ABCC2). J Pharmacol Exp Ther 317:579–589.
  • Cizkova, D., Morky, J., Micuda, S., Osterreicher, J., Martinkova, J. (2005). Expression of MRP2 and MDR1 transporters and other hepatic markers in rat and human liver and in WRL 68 cell line. Physiol Res 54:419–428.
  • Conrad, S., Viertelhaus, A., Orzechowski, A., Hoogstraate, J., Gjellan, K., Schrenk, D., et al. (2001). Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1. Toxicology 156:81–91.
  • Corpechot, C., Ping, C., Wendum, D., Matsuda, F., Barbu, V., Poupon, R. (2006). Identification of a novel 974C–>G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids. Am J Gastroenterol 101:2427–2432.
  • Courtois, A., Payen, L., Guillouzo, A., Fardel, O. (1999). Upregulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone. FEBS Lett 459:381–385.
  • Courtois, A., Payen, L., Le Ferrec, E., Scheffer, G. L., Trinquart, Y., Guillouzo, A., et al. (2002). Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes. Biochem Pharmacol 63:333–341.
  • Cui, X., Kobayashi, Y., Hayakawa, T., Hirano, S. (2004). Arsenic speciation in bile and urine following oral and intravenous exposure to inorganic and organic arsenics in rats. Toxicol Sci 82:478–487.
  • Cui, Y. J., Aleksunes, L. M., Tanaka, Y., Goedken, M. J., Klaassen, C. D. (2009). Compensatory induction of liver efflux transporters in response to ANIT-induced liver injury is impaired in FXR-null mice. Toxicol Sci 110:47–60. [Epub 2009 Apr 30]
  • de Zwart, L., Scholten, M., Monbaliu, J. G., Annaert, P. P., Van Houdt, J. M., Van den Wyngaert, I., et al. (2008). The ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod Toxicol 26:220–230.
  • Dean, M., Annilo, T. (2005). Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu Rev Genomics Hum Genet 6:123–142.
  • Dean, M., Rzhetsky, A., Allikmets, R. (2001). The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11:1156–1166.
  • Demeilliers, C., Jacquemin, E., Barbu, V., Mergey, M., Paye, F., Fouassier, L., et al. (2006). Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulation. Hepatology 43:1125–1134.
  • Demeule, M., Brossard M., Beliveau, R. (1999a). Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am J Physiol 277:F832–F840.
  • Demeule, M., Jodoin, J., Beaulieu, E., Brossard, M., Beliveau, R. (1999b). Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett 442:208–214.
  • Denk, G. U., Soroka, C. J., Takeyama, Y., Chen, W. S., Schuetz, J. D., Boyer, J. L. (2004). Multidrug resistance-associated protein 4 is upregulated in liver but downregulated in kidney in obstructive cholestasis in the rat. J Hepatol 40:585–591.
  • Denson, L. A., Auld, K. L., Schiek, D. S., McClure, M. H., Mangelsdorf, D. J., Karpen, S. J. (2000). Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation. J Biol Chem 275:8835–8843.
  • Denson, L. A., Bohan, A., Held, M. A., Boyer, J. L. (2002). Organ-specific alterations in RAR alpha:RXR alpha abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis. Gastroenterology 123:599–607.
  • Ding, S., Gong, B. D., Yu, J., Gu, J., Zhang, H. Y., Shang, Z. B., et al. (2004). Methylation profile of the promoter CpG islands of 14 “drug-resistance” genes in hepatocellular carcinoma. World J Gastroenterol 10:3433–3440.
  • Dombrowski, F., Kubitz, R., Chittattu, A., Wettstein, M., Saha, N., Haussinger, D. (2000). Electron-microscopic demonstration of multidrug resistance protein 2 (Mrp2) retrieval from the canalicular membrane in response to hyperosmolarity and lipopolysaccharide. Biochem J 348(Pt 1):183–188.
  • Donner, M. G., Keppler, D. (2001). Upregulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology 34:351–359.
  • Donner, M. G., Schumacher, S., Warskulat, U., Heinemann, J., Haussinger, D. (2007). Obstructive cholestasis induces TNF-alpha- and IL-1-mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2. Am J Physiol Gastrointest Liver Physiol 293:G1134–G1146.
  • Donner, M. G., Warskulat, U., Saha, N., Haussinger, D. (2004). Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPS. Biol Chem 385:331–339.
  • Douet, V., Heller, M. B., Le Saux, O. (2007). DNA methylation and Sp1 binding determine the tissue-specific transcriptional activity of the mouse Abcc6 promoter. Biochem Biophys Res Commun 354:66–71.
  • Douet, V., VanWart, C. M., Heller, M. B., Reinhard, S., Le Saux, O. (2006). HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression. Biochim Biophys Acta 1759:426–436.
  • Dransfeld, O., Gehrmann, T., Kohrer, K., Kircheis, G., Holneicher, C., Haussinger, D., et al. (2005). Oligonucleotide microarray analysis of differential transporter regulation in the regenerating rat liver. Liver Int 25:1243–1258.
  • Elferink, M. G., Olinga, P., Draaisma, A. L., Merema, M. T., Faber, K. N., Slooff, M. J., et al. (2004). LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 287:G1008–G1016.
  • Elias, E., Mills, C. O. (2007). Coordinated defence and the liver. Clin Med 7:180–184.
  • Fickert, P., Stoger, U., Fuchsbichler, A., Moustafa, T., Marschall, H. U., Weiglein, A. H., et al. (2007). A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 171:525–536.
  • Fickert, P., Wagner, M., Marschall, H. U., Fuchsbichler, A., Zollner, G., Tsybrovskyy, O., et al. (2006). 24-norursodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology 130:465–481.
  • Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Pojer, C., Zenz, R., et al. (2001). Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 121:170–183.
  • Fitz, J. G., Basavappa, S., McGill, J., Melhus, O., Cohn, J. A. (1993). Regulation of membrane chloride currents in rat bile duct epithelial cells. J Clin Invest 91:319–328.
  • Fouassier, L., Beaussier, M., Schiffer, E., Rey, C., Barbu, V., Mergey, M., et al. (2007). Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. Am J Physiol Gastrointest Liver Physiol 293:G25–G35.
  • Fromm, M. F., Leake, B., Roden, D. M., Wilkinson, G. R., Kim, R. B. (1999). Human MRP3 transporter: identification of the 5′-flanking region, genomic organization and alternative splice variants. Biochim Biophys Acta 1415:369–374.
  • Fujiyama, N., Shitara, Y., Ito, K., Masubuchi, Y., Horie, T. (2007). Downregulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury. Biol Pharm Bull 30:556–561.
  • Fukumoto, K., Kikuchi, S., Itoh, N., Tamura, A., Hata, M., Yamagishi, H., et al. (2007). Effects of genetic backgrounds on hyperbilirubinemia in radixin-deficient mice due to different expression levels of Mrp3. Biochim Biophys Acta 1772:298–306.
  • Gao, B., St. Pierre, M. V., Stieger, B., Meier, P. J. (2004). Differential expression of bile salt and organic anion transporters in developing rat liver. J Hepatol 41:201–208.
  • Garrovo, C., Rosati, A., Bartoli, F., Decorti, G. (2006). St John’s wort modulation and developmental expression of multidrug transporters in the rat. Phytother Res 20:468–473.
  • Geier, A., Dietrich, C. G., Grote, T., Beuers, U., Prufer, T., Fraunberger, P., et al. (2005a). Characterization of organic anion transporter regulation, glutathione metabolism, and bile formation in the obese Zucker rat. J Hepatol 43:1021–1030.
  • Geier, A., Dietrich, C. G., Lammert, F., Orth, T., Mayet, W. J., Matern, S., et al. (2002a). Regulation of organic anion transporters in a new rat model of acute and chronic cholangitis resembling human primary sclerosing cholangitis. J Hepatol 36:718–724.
  • Geier, A., Dietrich, C. G., Voigt, S., Ananthanarayanan, M., Lammert, F., Schmitz, A., et al. (2005b). Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol 289:G831–G841.
  • Geier, A., Dietrich, C. G., Voigt, S., Kim, S. K., Gerloff, T., Kullak-Ublick, G. A., et al. (2003a). Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38:345–354.
  • Geier, A., Kim, S. K., Gerloff, T., Dietrich, C. G., Lammert, F., Karpen, S. J., et al. (2002b). Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride. J Hepatol 37:198–205.
  • Geier, A., Mertens, P. R., Gerloff, T., Dietrich, C. G., En-Nia, A., Kullak-Ublick, G. A., et al. (2003b). Constitutive rat multidrug-resistance protein 2 gene transcription is downregulated by Y-box protein 1. Biochem Biophys Res Commun 309:612–618.
  • Gerloff, T., Geier, A., Stieger, B., Hagenbuch, B., Meier, P. J., Matern, S., et al. (1999). Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. Gastroenterology 117:1408–1415.
  • Ghanem, C. I., Gomez, P. C., Arana, M. C., Perassolo, M., Ruiz, M. L., Villanueva, S. S., et al. (2004). Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. Biochem Pharmacol 68:791–798.
  • Ghose, R., Guo, T., Haque, N. (2009). Regulation of gene expression of hepatic drug-metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid. Arch Biochem Biophys 481:123–130.
  • Glaser, SS, Gaudio, E, Rao, A, Pierce, LM, Onori, P, Franchitto, A, et al. (2009). Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium. Lab Invest 89:456–469.
  • Gonzalez, M. A., Roma, M. G., Bernal, C. A., Alvarez Mde, L., Carrillo, M. C. (2004). Biliary secretory function in rats chronically intoxicated with aluminum. Toxicol Sci 79:189–195.
  • Gradhand, U., Lang, T., Schaeffeler, E., Glaeser, H., Tegude, H., Klein, K., et al. (2008). Variability in human hepatic MRP4 expression: influence of cholestasis and genotype. Pharmacogenomics J 8:42–52.
  • Gu, X., Ke, S., Liu, D., Sheng, T., Thomas, P. E., Rabson, A. B., et al. (2006). Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 281:17882–17889.
  • Gu, X., Ke Manautou, J. E. (2009). Transcriptional regulation of human multidrug resistance associated protein 4 gene expression. The Toxicologist - supplement to Toxicological Sciences 108:154 .
  • Guimbellot, J. S., Fortenberry, J. A., Siegal, G. P., Moore, B., Wen, H., Venglarik, C., et al. (2008). Role of oxygen availability in CFTR expression and function. Am J Respir Cell Mol Biol 39:514–521.
  • Guo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Jr., Kliewer, S. A., et al. (2003). Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J Biol Chem 278:45062–45071.
  • Gyamfi, M. A., Tanaka, Y., He, L., Klaassen, C. D., Wan, Y. J. (2009). Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice. Toxicol Appl Pharmacol 234:166–178.
  • Gyamfi, M. A., Wan, Y. J. (2009). Mechanisms of resistance of hepatocyte retinoid X receptor alpha-null mice to WY-14,643-induced hepatocyte proliferation and cholestasis. J Biol Chem 284:9321–9330.
  • Habib, G. M., Shi, Z. Z., Ou, C. N., Kala, G., Kala, S. V., Lieberman, M. W. (2000). Altered gene expression in the liver of gamma-glutamyl transpeptidase-deficient mice. Hepatology 32:556–562.
  • Hagenbuch, N., Reichel, C., Stieger, B., Cattori, V., Fattinger, K. E., Landmann, L., et al. (2001). Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver. J Hepatol 34:881–887.
  • Halwachs, S., Kneuer, C., Honscha, W. (2005). Endogenous expression of liver-specific drug transporters for organic anions in the rat hepatocytoma fusion cell line HPCT-1E3. Eur J Cell Biol 84:677–686.
  • Han, Y., Sugiyama, Y. (2006). Expression and regulation of breast cancer resistance protein and multidrug resistance-associated protein 2 in BALB/c mice. Biol Pharm Bull 29:1032–1035.
  • Hannivoort, R. A., Dunning, S., Vander Borght, S., Schroyen, B., Woudenberg, J., Oakley, F. et, al. (2008). Multidrug resistance-associated proteins are crucial for the viability of activated rat hepatic stellate cells. Hepatology 48:624–634.
  • Harris, K. E., Jeffery, E. H. (2008). Sulforaphane and erucin increase MRP1 and MRP2 in human carcinoma cell lines. J Nutr Biochem 19:246–254.
  • Hartmann, G., Cheung, A. K., Piquette-Miller, M. (2002). Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J Pharmacol Exp Ther 303:273–281.
  • Hayashi, A., Suzuki, H., Itoh, K., Yamamoto, M., Sugiyama, Y. (2003). Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem Biophys Res Commun 310:824–829.
  • Hidemura, K., Zhao, Y. L., Ito, K., Nakao, A., Tatsumi, Y., Kanazawa, H., et al. (2003). Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by downregulation of hepatic P-glycoprotein and multidrug resistance-associated protein Mrp2. Antimicrob Agents Chemother 47:1636–1642.
  • Higuchi, K., Kobayashi, Y., Kuroda, M., Tanaka, Y., Itani, T., Araki, J., et al. (2004). Modulation of organic anion transporting polypeptide 1 and multidrug resistance protein 3 expression in the liver and kidney of Gunn rats. Hepatol Res 29:60–66.
  • Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A. L., Karlsson, J. (2007). Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos 35:1333–1340.
  • Hinoshita, E., Taguchi, K., Inokuchi, A., Uchiumi, T., Kinukawa, N., Shimada, M., et al. (2001). Decreased expression of an ATP-binding cassette transporter, MRP2, in human livers with hepatitis C virus infection. J Hepatol 35:765–773.
  • Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., et al. (1998). Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats. Mol Pharmacol 53:1068–1075.
  • Hisaeda, K., Inokuchi, A., Nakamura, T., Iwamoto, Y., Kohno, K., Kuwano, M., et al. (2004). Interleukin-1beta represses MRP2 gene expression through inactivation of interferon regulatory factor 3 in HepG2 cells. Hepatology 39:1574–1582.
  • Hitzl, M., Klein, K., Zanger, U. M., Fritz, P., Nussler, A. K., Neuhaus, P., et al. (2003). Influence of omeprazole on multidrug resistance protein 3 expression in human liver. J Pharmacol Exp Ther 304:524–530.
  • Hoffmaster, K. A., Turncliff, R. Z., LeCluyse, E. L., Kim, R. B., Meier, P. J., Brouwer, K. L. (2004). P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide. Pharm Res 21:1294–1302.
  • Hrebicek, M., Jirasek, T., Hartmannova, H., Noskova, L., Stranecky, V., Ivanek, R., et al. (2007). Rotor-type hyperbilirubinaemia has no defect in the canalicular bilirubin export pump. Liver Int 27:485–491.
  • Hu, R., Shen, G., Yerramilli, U. R., Lin, W., Xu, C., Nair, S., Kong, A. N. (2006). In vivo pharmacokinetics, activation of MAPK signaling, and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice. Arch Pharm Res 29:911–920.
  • Hu, X., Plomp, A. S., van Soest, S., Wijnholds, J. de, Jong, P. T., Bergen, A. A. (2003). Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update. Surv Ophthalmol 48:424–438.
  • Hyogo, H, Tazuma, S, Nishioka, T, Ochi, H, Yamaguchi, A, Numata, Y, et al. (2001). Phospholipid alterations in hepatocyte membranes and transporter protein changes in cholestatic rat model. Dig Dis Sci 46:2089–2097.
  • Inokuchi, A., Hinoshita, E., Iwamoto, Y., Kohno, K., Kuwano, M., Uchiumi, T. (2001). Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter. J Biol Chem 276:46822–46829.
  • Jedlitschky, G., Hoffmann, U., Kroemer, H. K. (2006). Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Exp Opin Drug Metab Toxicol 2:351–366.
  • Jiang, H., Chen, K., He, J., Pan, F., Li, J., Chen, J., et al. (2009). Association of pregnane X receptor with multidrug resistance-related protein 3 and its role in human colon cancer chemoresistance. J Gastrointest Surg 13:1831–1838. [Epub 2009 Jul 11]
  • Jiang, Q., Matsuzaki, Y., Li, K., Uitto, J. (2006). Transcriptional regulation and characterization of the promoter region of the human ABCC6 gene. J Invest Dermatol 126:325–335.
  • Jigorel, E., Le Vee, M., Boursier-Neyret, C., Parmentier, Y., Fardel, O. (2006). Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 34:1756–1763.
  • Johnson, B. M., Zhang, P., Schuetz, J. D., Brouwer, K. L. (2006). Characterization of transport protein expression in multidrug resistance-associated protein (Mrp) 2-deficient rats. Drug Metab Dispos 34:556–562.
  • Johnson, D. R., Guo, G. L., Klaassen, C. D. (2002a). Expression of rat multidrug resistance protein 2 (Mrp2) in male and female rats during normal and pregnenolone-16alpha-carbonitrile (PCN)-induced postnatal ontogeny. Toxicology 178:209–219.
  • Johnson, D. R., Habeebu, S. S., Klaassen, C. D. (2002b). Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2. Toxicol Sci 66:16–26.
  • Johnson, D. R., Klaassen, C. D. (2002). Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. Toxicol Sci 67:182–189.
  • Jones, B. R., Li, W., Cao, J., Hoffman, T. A., Gerk, P. M., Vore, M. (2005). The role of protein synthesis and degradation in the post-transcriptional regulation of rat multidrug resistance-associated protein 2 (Mrp2, Abcc2). Mol Pharmacol 68:701–710.
  • Kameyama, N., Arisawa, S., Ueyama, J., Kagota, S., Shinozuka, K., Hattori, A., et al. (2008). Increase in P-glycoprotein accompanied by activation of protein kinase Calpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes. Biochim Biophys Acta 1782:355–360.
  • Kamisako, T., Ogawa, H. (2005). Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis. J Gastroenterol Hepatol 20:1429–1434.
  • Kang-Park, S., Dray-Charier, N., Munier, A., Brahimi-Horn, C., Veissiere, D., Picard, J., et al. (1998). Role for PKC alpha and PKC epsilon in downregulation of CFTR mRNA in a human epithelial liver cell line. J Hepatol 28:250–262.
  • Kanno, K., Tazuma, S., Niida, S., Chayama, K. (2003). Unique reciprocal changes of hepatocellular membrane transporter expression and fluidity in rats with selective biliary obstruction. Hepatol Res 26:157–163.
  • Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., et al. (2002). Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277:2908–2915.
  • Kauffmann, H. M., Keppler, D., Gant, T. W., Schrenk, D. (1998). Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen. Arch Toxicol 72:763–768.
  • Kauffmann, H. M., Keppler D., Kartenbeck J., Schrenk, D. (1997). Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes. Hepatology 26:980–985.
  • Kauffmann, H. M., Schrenk, D. (1998). Sequence analysis and functional characterization of the 5′-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. Biochem Biophys Res Commun 245:325–331.
  • Kauffmann, H. M., Vorderstemann, B., Schrenk, D. (2001). Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites. Toxicology 167:25–35.
  • Kawaguchi, T., Sakisaka, S., Mitsuyama, K., Harada, M., Koga, H., Taniguchi, E., et al. (2000). Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis. Hepatology 31:1285–1295.
  • Kawase, A., Yoshida, I., Tsunokuni, Y., Iwaki, M. (2007). Decreased PXR and CAR inhibit transporter and CYP mRNA levels in the liver and intestine of mice with collagen-induced arthritis. Xenobiotica 37:366–374.
  • Keitel, V., Burdelski, M., Warskulat, U., Kuhlkamp, T., Keppler, D., Haussinger, D., et al. (2005). Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 41:1160–1172.
  • Kelley, K. A., Stamm, S., Kozak, C. A. (1992). Expression and chromosome localization of the murine cystic fibrosis transmembrane conductance regulator. Genomics 13:381–388.
  • Keppler, D., Konig, J. (1997). Hepatic canalicular membrane 5: expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J 11:509–516.
  • Khemawoot, P., Maruyama, C., Tsukada, H., Noda, H., Ishizaki, J., Yokogawa, K., et al. (2007). Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride. Biopharm Drug Dispos 28:331–338.
  • Kikuchi, S., Hata, M., Fukumoto, K., Yamane, Y., Matsui, T., Tamura, A., et al. (2002). Radixin deficiency causes conjugated hyperbilirubinemia with loss of Mrp2 from bile canalicular membranes. Nat Genet 31:320–325.
  • Kim, M. S., Liu, D. Q., Strauss, J. R., Capodanno, I., Yao, Z., Fenyk-Melody, J. E., et al. (2003). Metabolism and disposition of gemfibrozil in Wistar and multidrug resistance-associated protein 2-deficient TR− rats. Xenobiotica 33:1027–1042.
  • Kim, M. S., Wang, S., Shen, Z., Kochansky, C. J., Strauss, J. R., Franklin, R. B., et al. (2004). Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and Sprague-Dawley rats: implications of decreased glucuronidation in obese Zucker rats. Drug Metab Dispos 32:909–914.
  • Kim, P. K., Chen, J., Andrejko, K. M., Deutschman, C. S. (2000). Intra-abdominal sepsis downregulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats. Shock 14:176–181.
  • Kinnman, N., Lindblad, A., Housset, C., Buentke, E., Scheynius, A., Strandvik, B., et al. (2000). Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis. Hepatology 32:334–340.
  • Kipp, H., Arias, I. M. (2000). Intracellular trafficking and regulation of canalicular ATP-binding cassette transporters. Semin Liver Dis 20:339–351.
  • Kitada, H., Miyata, M., Nakamura, T., Tozawa, A., Honma, W., Shimada, M., et al. (2003). Protective role of hydroxysteroid sulfotransferase in lithocholic acid-induced liver toxicity. J Biol Chem 278:17838–17844.
  • Kitanaka, S., Sato, U., Igarashi, T. (2007). Regulation of human insulin, IGF-I, and multidrug resistance protein 2 promoter activity by hepatocyte nuclear factor (HNF)-1beta and HNF-1alpha and the abnormality of HNF-1beta mutants. J Endocrinol 192:141–147.
  • Kiuchi, Y., Suzuki, H., Hirohashi, T., Tyson, C. A., Sugiyama, Y. (1998). cDNA cloning and inducible expression of human multidrug resistance-associated protein 3 (MRP3). FEBS Lett 433:149–152.
  • Kocher, O., Yesilaltay, A., Shen, C. H., Zhang, S., Daniels, K., Pal, R., et al. (2008). Influence of PDZK1 on lipoprotein metabolism and atherosclerosis. Biochim Biophys Acta 1782:310–316.
  • Kojima, H., Nies, A. T., Konig, J., Hagmann, W., Spring, H., Uemura, M., et al. (2003). Changes in the expression and localization of hepatocellular transporters and radixin in primary biliary cirrhosis. J Hepatol 39:693–702.
  • Komuta, M., Spee, B., Vander Borght, S. De, Vos, R., Verslype, C., Aerts, R. et, al. (2008). Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 47:1544–1556.
  • Kong, F. M., Sui, C. Y., Li, Y. J., Guo, K. J., Guo, R. X. (2006). Hepatobiliary membrane transporters involving in the formation of cholesterol calculus. Hepatobil Pancreat Dis Int 5:286–289.
  • Konig, J., Rost, D., Cui, Y., Keppler, D. (1999). Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29:1156–1163.
  • Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., et al. (1997). Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1) in human cancer cell lines. Cancer Res 57:3537–3547.
  • Kool, M., van der Linden, M., de Haas, M., Baas, F., Borst, P. (1999). Expression of human MRP6, a homologue of the multidrug resistance protein gene, MRP1, in tissues and cancer cells. Cancer Res 59:175–182.
  • Kruh, G. D., Guo, Y., Hopper-Borge, E., Belinsky, M. G., Chen, Z. S. (2007). ABCC10, ABCC11, and ABCC12. Pflugers Arch 453:675–684.
  • Kubitz, R., Warskulat, U., Schmitt, M., Haussinger, D. (1999a). Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes. Biochem J 340(Pt 3):585–591.
  • Kubitz, R., Wettstein, M., Warskulat, U., Haussinger, D. (1999b). Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone. Gastroenterology 116:401–410.
  • Kubo, K., Sekine, S., Saito, M. (2006). Induction of multidrug resistance-associated protein MRP3 in the liver of rats fed with docosahexaenoic acid. Biosci Biotechnol Biochem 70:1672–1680.
  • Kullak-Ublick, G. A., Baretton, G. B., Oswald, M., Renner, E. L., Paumgartner, G., Beuers, U. (2002). Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis. Hepatol Res 23:78–82.
  • Kuroda, M., Kobayashi, Y., Tanaka, Y., Itani, T., Mifuji, R., Araki, J., et al. (2004). Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats. J Gastroenterol Hepatol 19:146–153.
  • Kurz, E. U., Cole, S. P., Deeley, R. G. (2001). Identification of DNA-protein interactions in the 5′ flanking and 5′ untranslated regions of the human multidrug resistance protein (MRP1) gene: evaluation of a putative antioxidant response element/AP-1 binding site. Biochem Biophys Res Commun 285:981–990.
  • Lam, P., Wang, R., Ling, V. (2005). Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. Biochemistry 44:12598–12605.
  • Lambert, C. B., Spire, C., Claude, N., Guillouzo, A. (2009). Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol 234:345–360.
  • Lang, T., Hitzl, M., Burk, O., Mornhinweg, E., Keil, A., Kerb, R., et al. (2004). Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. Pharmacogenetics 14:155–164.
  • Laouari, D., Yang, R., Veau, C., Blanke, I., Friedlander, G. (2001). Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure. Am J Physiol Renal Physiol 280:F636–F645.
  • Le Vee, M., Gripon, P., Stieger, B., Fardel, O. (2008). Downregulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta. Drug Metab Dispos 36:217–222.
  • Le Vee, M., Jigorel, E., Glaise, D., Gripon, P., Guguen-Guillouzo, C., Fardel, O. (2006). Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line. Eur J Pharm Sci 28:109–117.
  • Lee, G., Piquette-Miller, M. (2001). Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can J Physiol Pharmacol 79:876–884.
  • Lee, J. K., Leslie, E. M., Zamek-Gliszczynski, M. J., Brouwer, K. L. (2008). Modulation of trabectedin (ET-743) hepatobiliary disposition by multidrug resistance-associated proteins (Mrps) may prevent hepatotoxicity. Toxicol Appl Pharmacol 228:17–23.
  • Lee, K., Belinsky, M. G., Bell, D. W., Testa, J. R., Kruh, G. D. (1998). Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Res 58:2741–2747.
  • Lee, T. K., Hammond, C. L., Ballatori, N. (2001). Intracellular glutathione regulates taurocholate transport in HepG2 cells. Toxicol Appl Pharmacol 174:207–215.
  • Li, G. X., Pei, Q. L., Gao, Y. (2004). [Toxic effect of arsenite on the expression of liver multidrug resistance-associated protein 2 in rat]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 22:264–266.
  • Li, N., Zhang, Y., Hua, F., Lai, Y. (2009). Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human. Drug Metab Dispos 37:66–73.
  • Li, Q., Jiang, Q., Larusso, J., Klement, J. F., Sartorelli, A. C., Belinsky, M. G., et al. (2007). Targeted ablation of Abcc1 or Abcc3 in Abcc6(–/–) mice does not modify the ectopic mineralization process. Exp Dermatol 16:853–859.
  • Li, S., Moy, L., Pittman, N., Shue, G., Aufiero, B., Neufeld, E. J., et al. (1999). Transcriptional repression of the cystic fibrosis transmembrane conductance regulator gene, mediated by CCAAT displacement protein/cut homolog, is associated with histone deacetylation. J Biol Chem 274:7803–7815.
  • Lickteig, A. J., Fisher, C. D., Augustine, L. M., Aleksunes, L. M., Besselsen, D. G., Slitt, A. L., et al. (2007a). Efflux transporter expression and acetaminophen metabolite excretion are altered in rodent models of nonalcoholic fatty liver disease. Drug Metab Dispos 35:1970–1978.
  • Lickteig, A. J., Slitt, A. L., Arkan, M. C., Karin, M., Cherrington, N. J. (2007b). Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab Dispos 35:402–409.
  • Liu, J. J., Glickman, J. N., Masyuk, A. I., Larusso, N. F. (2008). Cholangiocyte bile salt transporters in cholesterol gallstone-susceptible and resistant inbred mouse strains. J Gastroenterol Hepatol 23:1596–1602.
  • Liu, L., Sun, H., Valji, W. Y., Pang, K. S. (2007). Transporters, enzymes, and enalapril removal in a rat (CC531-induced) liver metastatic model. Am J Physiol Gastrointest Liver Physiol 293:G1078–G1088.
  • Lu, H., Klaassen, C. (2008). Gender differences in mRNA expression of ATP-binding cassette efflux and bile acid transporters in kidney, liver, and intestine of 5/6 nephrectomized rats. Drug Metab Dispos 36:16–23.
  • Luttringer, O., Theil, F. P., Lave, T., Wernli-Kuratli, K., Guentert, T. W., de Saizieu, A. (2002). Influence of isolation procedure, extracellular matrix, and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes. Biochem Pharmacol 64:1637–1650.
  • Ma, L., Krishnamachary, N., Center, M. S. (1995). Phosphorylation of the multidrug resistance-associated protein gene encoded protein P190. Biochemistry 34:3338–3343.
  • Macias, R. I., Jimenez, S., Serrano, M. A., Monte, M. J., Marin, J. J. (2006). Effect of maternal cholestasis and treatment with ursodeoxycholic acid on the expression of genes involved in the secretion of biliary lipids by the neonatal rat liver. Life Sci 79:1014–1019.
  • Maher, J. M., Aleksunes, L. M., Dieter, M. Z., Tanaka, Y., Peters, J. M., Manautou, J. E., et al. (2008). Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Toxicol Sci 106:319–328.
  • Maher, J. M., Cheng, X., Slitt, A. L., Dieter, M. Z., Klaassen, C. D. (2005a). Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver. Drug Metab Dispos 33:956–962.
  • Maher, J. M., Cherrington, N. J., Slitt, A. L., Klaassen, C. D. (2006a). Tissue distribution and induction of the rat multidrug resistance-associated proteins 5 and 6. Life Sci 78:2219–2225.
  • Maher, J. M., Dieter, M. Z., Aleksunes, L. M., Slitt, A. L., Guo, G., Tanaka, Y., et al. (2007). Oxidative and electrophilic stress induces multidrug resistance-associated protein transporters via the nuclear factor-E2-related factor-2 transcriptional pathway. Hepatology 46:1597–1610.
  • Maher, J. M., Slitt, A. L., Callaghan, T. N., Cheng, X., Cheung, C., Gonzalez, F. J., et al. (2006b). Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1alpha. Biochem Pharmacol 72:512–522.
  • Maher, J. M., Slitt, A. L., Cherrington, N. J., Cheng, X., Klaassen, C. D. (2005b). Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (Mrp) family in mice. Drug Metab Dispos 33:947–955.
  • Makino, T., Ohtake, N., Watanabe, A., Tsuchiya, N., Imamura, S., Iizuka, S., et al. (2008). Downregulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury. Drug Metab Dispos 36:1438–1443.
  • Manohar, C. F., Bray, J. A., Salwen, H. R., Madafiglio, J., Cheng, A., Flemming, C., et al. (2004). MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma. Oncogene 23:753–762.
  • Marschall, H. U., Wagner, M., Zollner, G., Fickert, P., Diczfalusy, U., Gumhold, J., et al. (2005). Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. Gastroenterology 129:476–485.
  • Marumo, T., Fukusato, T., Takikawa, H. (2004). Biliary excretion of bile acids and organic anions in rats with dichloroethylene-induced bile canalicular injury. J Gastroenterol 39:981–987.
  • Matsuzaki, Y., Nakano, A., Jiang, Q. J., Pulkkinen, L., Uitto, J. (2005). Tissue-specific expression of the ABCC6 gene. J Invest Dermatol 125:900–905.
  • McCarthy, T. C., Li, X., Sinal, C. J. (2005). Vitamin D receptor-dependent regulation of colon multidrug resistance-associated protein 3 gene expression by bile acids. J Biol Chem 280:23232–23242.
  • McCarthy, V. A., Harris, A. (2005). The CFTR gene and regulation of its expression. Pediatr Pulmonol 40:1–8.
  • Meier, Y., Pauli-Magnus, C., Zanger, U. M., Klein, K., Schaeffeler, E., Nussler, A. K., et al. (2006). Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology 44:62–74.
  • Mennone, A., Soroka, C. J., Cai, S. Y., Harry, K., Adachi, M., Hagey, L., et al. (2006). Mrp4−/– mice have an impaired cytoprotective response in obstructive cholestasis. Hepatology 43:1013–1021.
  • Merrell, M. D., Augustine, L. M., Slitt, A. L., Cherrington, N. J. (2008). Induction of drug metabolism enzymes and transporters by oltipraz in rats. J Biochem Mol Toxicol 22:128–135.
  • Micuda, S., Fuksa, L., Brcakova, E., Osterreicher, J., Cermanova, J., Cibicek, N., et al. (2008). Zonation of multidrug resistance-associated protein 2 in rat liver after induction with dexamethasone. J Gastroenterol Hepatol 23:e225–e230.
  • Minami, S., Ito, K., Honma, M., Ikebuchi, Y., Anzai, N., Kanai, Y., et al. (2009). Post-translational regulation of Abcc2 expression by SUMOylation system. Am J Physiol Gastrointest Liver Physiol 296:G406–G413.
  • Mizukoshi, E., Honda, M., Arai, K., Yamashita, T., Nakamoto, Y., Kaneko, S. (2008). Expression of multidrug resistance-associated protein 3 and cytotoxic T cell responses in patients with hepatocellular carcinoma. J Hepatol 49:946–954.
  • Moffit, J. S., Aleksunes, L. M., Maher, J. M., Scheffer, G. L., Klaassen, C. D., Manautou, J. E. (2006). Induction of hepatic transporters multidrug resistance-associated proteins (Mrp) 3 and 4 by clofibrate is regulated by peroxisome proliferator-activated receptor alpha. J Pharmacol Exp Ther 317:537–545.
  • Monte, M. J., Fernandez-Tagarro, M., Macias, R. I., Jimenez, F., Gonzalez-San Martin, F., Marin, J. J. (2005). Changes in the expression of genes related to bile acid synthesis and transport by the rat liver during hepatocarcinogenesis. Clin Sci (Lond) 109:199–207.
  • Moribe, T., Iizuka, N., Miura, T., Kimura, N., Tamatsukuri, S., Ishitsuka, H., et al. (2009). Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma. Int J Cancer .
  • Moustafa, M. A., Ogino, D., Nishimura, M., Ueda, N., Naito, S., Furukawa, M., et al. (2004). Comparative analysis of ATP-binding cassette (ABC) transporter gene expression levels in peripheral blood leukocytes and in liver with hepatocellular carcinoma. Cancer Sci 95:530–536.
  • Muguruma, M., Kawai, M., Dewa, Y., Nishimura, J., Saegusa, Y., Yasuno, H., et al. (2009). Threshold dose of piperonyl butoxide that induces reactive oxygen species-mediated hepatocarcinogenesis in rats. Arch Toxicol 83:183–193.
  • Muguruma, M., Unami, A., Kanki, M., Kuroiwa, Y., Nishimura, J., Dewa, Y., et al. (2007). Possible involvement of oxidative stress in piperonyl butoxide-induced hepatocarcinogenesis in rats. Toxicology 236:61–75.
  • Muhlfeld, A., Kubitz, R., Dransfeld, O., Haussinger, D., Wettstein, M. (2003). Taurine supplementation induces multidrug resistance protein 2 and bile salt export pump expression in rats and prevents endotoxin-induced cholestasis. Arch Biochem Biophys 413:32–40.
  • Muller, O., Schalla, C., Scheibner, J., Stange, E. F., Fuchs, M. (2002). Expression of liver plasma membrane transporters in gallstone-susceptible and gallstone-resistant mice. Biochem J 361:673–679.
  • Muredda, M., Nunoya, K., Burtch-Wright, R. A., Kurz, E. U., Cole, S. P., Deeley, R. G. (2003). Cloning and characterization of the murine and rat mrp1 promoter regions. Mol Pharmacol 64:1259–1269.
  • Nakamura, J., Nishida, T., Hayashi, K., Kawada, N., Ueshima, S., Sugiyama, Y., et al. (1999). Kupffer cell-mediated downregulation of rat hepatic CMOAT/MRP2 gene expression. Biochem Biophys Res Commun 255:143–149.
  • Nakazato, K., Yoshida, Y., Takemori, K., Kobayashi, K., Sakamoto, A. (2009). Expressions of genes encoding drug-metabolizing enzymes are altered after sevoflurane, isoflurane, propofol, or dexmedetomidine anesthesia. Biomed Res 30:17–24.
  • Naud, J., Michaud, J., Leblond, F. A., Lefrancois, S., Bonnardeaux, A., Pichette, V. (2008). Effects of chronic renal failure on liver drug transporters. Drug Metab Dispos 36:124–128.
  • Nezasa, K., Tian, X., Zamek-Gliszczynski, M. J., Patel, N. J., Raub, T. J., Brouwer, K. L. (2006). Altered hepatobiliary disposition of 5 (and 6)-carboxy-2prime;,7prime;-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout mice. Drug Metab Dispos 34:718–723.
  • Niemi, M., Arnold, K. A., Backman, J. T., Pasanen, M. K., Godtel-Armbrust, U., Wojnowski, L., et al. (2006). Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics. Pharmacogenet Genom 16:801–808.
  • Nies, A. T., Cantz, T., Brom, M., Leier, I., Keppler, D. (1998). Expression of the apical conjugate export pump, Mrp2, in the polarized hepatoma cell line, WIF-B. Hepatology 28:1332–1340.
  • Nies, A. T., Keppler, D. (2007). The apical conjugate efflux pump, ABCC2 (MRP2). Pflugers Arch 453:643–659.
  • Nies, A. T., Konig, J., Pfannschmidt, M., Klar, E., Hofmann, W. J., Keppler, D. (2001). Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int J Cancer 94:492–499.
  • Nishimura, M., Koeda, A., Morikawa, H., Satoh, T., Narimatsu, S., Naito, S. (2008). Comparison of inducibility of multidrug resistance (MDR)1, multidrug resistance-associated protein (MRP)1, and MRP2 mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes. Biol Pharm Bull 31:2068–2072.
  • Nishimura, M., Yamaguchi, M., Yamauchi, A., Ueda, N., Naito, S. (2005). Role of soybean oil fat emulsion in the prevention of hepatic xenobiotic transporter mRNA up- and downregulation induced by overdose of fat-free total parenteral nutrition in infant rats. Drug Metab Pharmacokinet 20:46–54.
  • Nishioka, T, Hyogo, H, Numata, Y, Yamaguchi, A, Kobuke, T, Komichi, D, et al. (2005). A nuclear receptor-mediated choleretic action of fibrates is associated with enhanced canalicular membrane fluidity and transporter activity mediating bile acid-independent bile secretion. J Atheroscler Thromb 12:211–217.
  • Nishiya, T., Kataoka, H., Mori, K., Goto, M., Sugawara, T., Furuhama, K. (2006). Tienilic acid enhances hyperbilirubinemia in Eisai hyperbilirubinuria rats through hepatic multidrug resistance-associated protein 3 and heme oxygenase-1 induction. Toxicol Sci 91:651–659.
  • Nowicki, M. T., Aleksunes, L. M., Sawant, S. P., Dnyanmote, A. V., Mehendale, H. M, Manautou, J. E. (2008). Renal and hepatic transporter expression in type 2 diabetic rats. Drug Metab Lett 2:11–17.
  • Ogawa, K., Suzuki, H., Hirohashi, T., Ishikawa, T., Meier, P. J., Hirose, K., et al. (2000). Characterization of inducible nature of MRP3 in rat liver. Am J Physiol Gastrointest Liver Physiol 278:G438–G446.
  • Ogura, J., Kobayashi, M., Itagaki, S., Hirano, T., Iseki, K. (2008). Alteration of Mrp2 and P-gp expression, including expression in remote organs, after intestinal ischemia-reperfusion. Life Sci 82:1242–1248.
  • Okada, K., Shoda, J., Taguchi, K., Maher, J. M., Ishizaki, K., Inoue, Y, et al. (2008). Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am J Physiol Gastrointest Liver Physiol 295:G735–G747.
  • Okumura, H., Katoh, M., Minami, K., Nakajima, M., Yokoi, T. (2007). Change of drug excretory pathway by CCl4-induced liver dysfunction in rat. Biochem Pharmacol 74:488–495.
  • Olinga, P., Elferink, M. G., Draaisma, A. L., Merema, M. T., Castell, J. V., Perez, G., et al. (2008). Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. Eur J Pharm Sci 33:380–389.
  • Ortiz, D. F., Li, S., Iyer, R., Zhang, X., Novikoff, P., Arias, I. M. (1999). MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte. Am J Physiol 276:G1493–G1500.
  • Osabe, M., Sugatani, J., Fukuyama, T., Ikushiro, S., Ikari, A., Miwa, M. (2008). Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet. Drug Metab Dispos 36:294–302.
  • Oscarson, M., Zanger, U. M., Rifki, O. F., Klein, K., Eichelbaum, M., Meyer, U. A. (2006). Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine. Clin Pharmacol Ther 80:440–456.
  • Oshima, H., Kon, J., Ooe, H., Hirata, K., Mitaka, T. (2008). Functional expression of organic anion transporters in hepatic organoids reconstructed by rat small hepatocytes. J Cell Biochem 104:68–81.
  • Oswald, M., Kullak-Ublick, G. A., Paumgartner, G., Beuers, U. (2001). Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis. Liver 21:247–253.
  • Parody, J. P., Alvarez Mde, L., Quiroga, A., Ronco, M. T., Frances, D., Carnovale, C., et al. (2007). Hepatocytes isolated from preneoplastic rat livers are resistant to ethacrynic acid cytotoxicity. Arch Toxicol 81:565–573.
  • Pascolo, L., Bogoni, S., Spano, A., Demori, E., Amoroso, A., Crovella, S. (2001). Fluorescent RT in situ PCR detection of MRP1 mRNA in human HCV infected liver. Eur J Histochem 45:105–108.
  • Pascolo, L., Fernetti, C., Pirulli, D., Bogoni, S., Garcia-Mediavilla, M. V., Spano, A., et al. (2000). Detection of MRP1 mRNA in human tumors and tumor cell lines by in situ RT-PCR. Biochem Biophys Res Commun 275:466–471.
  • Patel, N. J., Zamek-Gliszczynski, M. J., Zhang, P., Han, Y. H., Jansen, P. L., Meier, P. J., et al. (2003). Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions. Mol Pharmacol 64:154–159.
  • Paulusma, C. C., de Waart, D. R., Kunne, C., Mok, K. S., Elferink, R. P. (2009). Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content. J Biol Chem 284:9947–9954.
  • Paulusma, C. C., Kothe, M. J., Bakker, C. T., Bosma, P. J., van Bokhoven, I. van, Marle, J. et, al. (2000). Zonal downregulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver. Hepatology 31:684–693.
  • Payen, L., Courtois, A., Campion, J. P., Guillouzo, A., Fardel, O. (2000). Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes. Biochem Pharmacol 60:1967–1975.
  • Payen, L., Courtois, A., Langouet, S., Guillouzo, A., Fardel, O. (2001). Unaltered expression of multidrug resistance transporters in polycyclic aromatic hydrocarbon-resistant rat liver cells. Toxicology 156:109–117.
  • Pei, Q. L., Kobayashi, Y., Tanaka, Y., Taguchi, Y., Higuchi, K., Kaito, M., et al. (2002). Increased expression of multidrug resistance-associated protein 1 (mrp1) in hepatocyte basolateral membrane and renal tubular epithelia after bile duct ligation in rats. Hepatol Res 22:58–64.
  • Pejchal, J., Osterreicher, J., Kuca, K., Jun, D., Bajgar, J., Kassa, J. (2008). The influence of acetylcholinesterase reactivators on selected hepatic functions in rats. Basic Clin Pharmacol Toxicol 103:119–123.
  • Petrick, J. S., Klaassen, C. D. (2007). Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport. Drug Metab Dispos 35:1806–1815.
  • Pizarro, M., Balasubramaniyan, N., Solis, N., Solar, A., Duarte, I., Miquel, J. F., et al. (2004). Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function. Gut 53:1837–1843.
  • Qadri, I., Hu, L. J., Iwahashi, M., Al-Zuabi, S., Quattrochi, L. C., Simon, F. R. (2009). Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue-specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2). Toxicol Appl Pharmacol 234:281–292.
  • Qadri, I., Iwahashi, M., Kullak-Ublick, G. A., Simon, F. R. (2006). Hepatocyte nuclear factor (HNF) 1 and HNF4 mediate hepatic multidrug resistance protein 2 upregulation during hepatitis C virus gene expression. Mol Pharmacol 70:627–636.
  • Ratajewski, M., Bartosz, G., Pulaski, L. (2006). Expression of the human ABCC6 gene is induced by retinoids through the retinoid X receptor. Biochem Biophys Res Commun 350:1082–1087.
  • Ratajewski, M., Boussac, H., Pulaski, L. (2009). Liver-specific enhancer in ABCC6 promoter—functional evidence from natural polymorphisms. Biochem Biophys Res Commun 383:73–77.
  • Ratajewski, M., Van de Ven, W. J., Bartosz, G., Pulaski, L. (2008). The human Pseudoxanthoma elasticum gene ABCC6 is transcriptionally regulated by PLAG family transcription factors. Hum Genet 124:451–463.
  • Rees, D. C., Johnson, E., Lewinson, O. (2009). ABC transporters: the power to change. Nat Rev Mol Cell Biol 10:218–227.
  • Ringpfeil, F., Pulkkinen, L., Uitto, J. (2001). Molecular genetics of Pseudoxanthoma elasticum. Exp Dermatol 10:221–228.
  • Rippin, S. J., Hagenbuch, B., Meier, P. J., Stieger, B. (2001). Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes. Hepatology 33:776–782.
  • Rius, M., Nies, A. T., Hummel-Eisenbeiss, J., Jedlitschky, G., Keppler, D. (2003). Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane. Hepatology 38:374–384.
  • Roelofsen, H., Hooiveld, G. J., Koning, H., Havinga, R., Jansen, P. L., Muller, M. (1999). Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRP1 transporting protein. J Cell Sci 112(Pt 9):1395–1404.
  • Roelofsen, H., Vos, T. A., Schippers, I. J., Kuipers, F., Koning, H., Moshage, H., et al. (1997). Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells. Gastroenterology 112:511–521.
  • Ros, J. E., Libbrecht, L., Geuken, M., Jansen, P. L., Roskams, T. A. (2003a). High expression of MDR1, MRP1, and MRP3 in the hepatic progenitor cell compartment and hepatocytes in severe human liver disease. J Pathol 200:553–560.
  • Ros, J. E., Roskams, T. A., Geuken, M., Havinga, R., Splinter, P. L., Petersen, B. E., et al. (2003b). ATP-binding cassette transporter gene expression in rat liver progenitor cells. Gut 52:1060–1067.
  • Rosati, A., Maniori, S., Decorti, G., Candussio, L., Giraldi, T., Bartoli, F. (2003). Physiological regulation of P-glycoprotein, MRP1, MRP2, and cytochrome P450 3A2 during rat ontogeny. Dev Growth Differ 45:377–387.
  • Rost, D., Kopplow, K., Gehrke, S., Mueller, S., Friess, H., Ittrich, C., et al. (2005). Gender-specific expression of liver organic anion transporters in rat. Eur J Clin Invest 35:635–643.
  • Ruiz, M. L., Villanueva, S. S., Luquita, M. G., Ikushiro, S., Mottino, A. D., Catania, V. A. (2007). Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of upregulation of multidrug resistance-associated protein 2. Drug Metab Dispos 35:2060–2066.
  • Ruiz, M. L., Villanueva, S. S., Luquita, M. G., Vore, M., Mottino, A. D., Catania, V. A. (2006). Ethynylestradiol increases expression and activity of rat liver MRP3. Drug Metab Dispos 34:1030–1034.
  • Russel, F. G., Koenderink, J. B., Masereeuw, R. (2008). Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci 29:200–207.
  • Saier, M. H., Jr., Yen, M. R., Noto, K., Tamang, D. G., Elkan, C. (2009). The Transporter Classification Database: recent advances. Nucleic Acids Res 37:D274–D278.
  • Sanchez Pozzi, E. J., Roma, M. G. (2009). Putative role for actin organization status in the dynamic localization of canalicular carriers under oxidative stress conditions. Am J Physiol Gastrointest Liver Physiol 296:G969.
  • Saurin, W., Hofnung, M., Dassa, E. (1999). Getting in or out: early segregation between importers and exporters in the evolution of ATP-binding cassette (ABC) transporters. J Mol Evol 48:22–41.
  • Schaap, F. G., van der Gaag, N. A., Gouma, D. J., Jansen, P. L. (2009). High expression of the bile salt—homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology 49:1228–1235.
  • Scheffer, G. L., Hu, X., Pijnenborg, A. C., Wijnholds, J., Bergen, A. A., Scheper, R. J. (2002a). MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest 82:515–518.
  • Scheffer, G. L., Kool, M., de Haas, M. de, Vree, J. M., Pijnenborg, A. C., Bosman, D. K., et al. (2002b). Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest 82:193–201.
  • Schrenk, D., Baus, P. R., Ermel, N., Klein, C., Vorderstemann, B., Kauffmann, H. M. (2001). Upregulation of transporters of the MRP family by drugs and toxins. Toxicol Lett 120:51–57.
  • Schuetz, E. G., Strom, S., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., et al. (2001). Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 276:39411–39418.
  • Sekine, S., Ito, K., Horie, T. (2006). Oxidative stress and Mrp2 internalization. Free Radic Biol Med 40:2166–2174.
  • Sekine, S., Ito, K., Horie, T. (2008). Canalicular Mrp2 localization is reversibly regulated by the intracellular redox status. Am J Physiol Gastrointest Liver Physiol 295:G1035–G1041.
  • Shen, D. W., Goldenberg, S., Pastan, I., Gottesman, M. M. (2000). Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake. J Cell Physiol 183:108–116.
  • Shen, H., Fan, Y., Yang, X., Burczynski, F. J., Li, P., Gong, Y. (2005). Increased expression of cystic fibrosis transmembrane conductance regulator in rat liver after common bile duct ligation. J Cell Physiol 203:599–603.
  • Shi, L. X., Ma, R., Lu, R., Xu, Q., Zhu, Z. F., Wang, L., et al. (2008). Reversal effect of tyroservatide (YSV) tripeptide on multidrug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. Cancer Lett 269:101–110.
  • Shibayama, Y., Ikeda, R., Motoya, T., Yamada, K. (2004). St. John’s wort (Hypericum perforatum) induces overexpression of multidrug resistance protein 2 (MRP2) in rats: a 30-day ingestion study. Food Chem Toxicol 42:995–1002.
  • Shibayama, Y., Ushinohama, K., Ikeda, R., Yoshikawa, Y., Motoya, T., Takeda, Y., et al. (2006). Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein, and organic anion transporters Oat1, Oat2, and Oat3 in rats. Cancer Sci 97:1260–1266.
  • Shinoda, C., Maruyama, M., Fujishita, T., Dohkan, J., Oda, H., Shinoda, K., et al. (2005). Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway. Int J Cancer 117:21–31.
  • Shoda, J., Kano, M., Oda, K., Kamiya, J., Nimura, Y., Suzuki, H., et al. (2001). The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function. Am J Gastroenterol 96:3368–3378.
  • Shoda, J., Miura, T., Utsunomiya, H., Oda, K., Yamamoto, M., Kano, M., et al. (2004). Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver. Hepatology 39:167–178.
  • Shoda, J., Suzuki, H., Suzuki, H., Sugiyama, Y., Hirouchi, M., Utsunomiya, H., et al. (2003). Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2/ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome. Hepatol Res 27:323–326.
  • Shu, M., Peng, C. H., Chen, H., Shen, B. Y., Qiu, W. H., Jiang, Z. H., et al. (2007). [Expression and localization of multidrug resistance-associated protein 2 and radixin after hepatic ischemia-reperfusion: experiment with rats]. Zhonghua Yi Xue Za Zhi 87:947–952.
  • Sidler Pfandler, M. A., Hochli, M., Inderbitzin, D., Meier, P. J., Stieger, B. (2004). Small hepatocytes in culture develop polarized transporter expression and differentiation. J Cell Sci 117:4077–4087.
  • Siewert, E., Dietrich, C. G., Lammert, F., Heinrich, P. C., Matern, S., Gartung, C., et al. (2004). Interleukin-6 regulates hepatic transporters during acute-phase response. Biochem Biophys Res Commun 322:232–238.
  • Simon, F. R., Iwahashi, M., Hu, L. J., Qadri, I., Arias, I. M., Ortiz, D., et al. (2006). Hormonal regulation of hepatic multidrug resistance-associated protein 2 (Abcc2) primarily involves the pattern of growth hormone secretion. Am J Physiol Gastrointest Liver Physiol 290:G595–G608.
  • Slitt, A. L., Allen, K., Morrone, J., Aleksunes, L. M., Chen, C., Maher, J. M., et al. (2007). Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis. Biochim Biophys Acta 1768:637–647.
  • Slitt, A. L., Cherrington, N. J., Dieter, M. Z., Aleksunes, L. M., Scheffer, G. L., Huang, W., et al. (2006a). Trans-stilbene oxide induces expression of genes involved in metabolism and transport in mouse liver via CAR and Nrf2 transcription factors. Mol Pharmacol 69:1554–1563.
  • Slitt, A. L., Cherrington, N. J., Fisher, C. D., Negishi, M., Klaassen, C. D. (2006b). Induction of genes for metabolism and transport by trans-stilbene oxide in livers of Sprague-Dawley and Wistar-Kyoto rats. Drug Metab Dispos 34:1190–1197.
  • Slitt, A. L., Cherrington, N. J., Maher, J. M., Klaassen, C. D. (2003). Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites. Drug Metab Dispos 31:1176–1186.
  • Soroka, C. J., Lee, J. M., Azzaroli, F., Boyer, J. L. (2001). Cellular localization and upregulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology 33:783–791.
  • Spirli, C., Nathanson, M. H., Fiorotto, R., Duner, E., Denson, L. A., Sanz, J. M., et al. (2001). Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. Gastroenterology 121:156–169.
  • Staudinger, J. L., Madan, A., Carol, K. M., Parkinson, A. (2003). Regulation of drug transporter gene expression by nuclear receptors. Drug Metab Dispos 31:523–527.
  • Stedman, C., Liddle, C., Coulter, S., Sonoda, J., Alvarez, J. G., Evans, R. M., et al. (2006). Benefit of farnesoid X receptor inhibition in obstructive cholestasis. Proc Natl Acad Sci U S A 103:11323–11328.
  • Stockel, B., Konig, J., Nies, A. T., Cui, Y., Brom, M., Keppler, D. (2000). Characterization of the 5′-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison with the multidrug resistance protein 3 (MRP3) gene. Eur J Biochem 267:1347–1358.
  • Sullivan, G. F., Yang, J. M., Vassil, A., Yang, J., Bash-Babula, J., Hait, W. N. (2000). Regulation of expression of the multidrug resistance protein MRP1 by p53 in human prostate cancer cells. J Clin Invest 105:1261–1267.
  • Sun, H., Frassetto, L., Benet, L. Z. (2006). Effects of renal failure on drug transport and metabolism. Pharmacol Ther 109:1–11.
  • Suzuki, T., Zhao, Y. L., Nadai, M., Naruhashi, K., Shimizu, A., Takagi, K., et al. (2006). Gender-related differences in expression and function of hepatic P-glycoprotein and multidrug resistance-associated protein (Mrp2) in rats. Life Sci 79:455–461.
  • Szabo, D. T., Richardson, V. M., Ross, D. G., Diliberto, J. J., Kodavanti, P. R., Birnbaum, L. S. (2009). Effects of perinatal PBDE exposure on hepatic phase I, phase II, phase III, and deiodinase 1 gene expression involved in thyroid hormone metabolism in male rat pups. Toxicol Sci 107:27–39.
  • Szakacs, G., Varadi, A., Ozvegy-Laczka, C., Sarkadi, B. (2008). The role of ABC transporters in drug absorption, distribution, metabolism, excretion, and toxicity (ADME-Tox). Drug Discov Today 13:379–393.
  • Takada, T., Suzuki, H., Sugiyama, Y. (2000). Characterization of 5′-flanking region of human MRP3. Biochem Biophys Res Commun 270:728–732.
  • Tamai, M., Ito, Y., Mirura, H., Tsukada, H., Yokogawa, K., Nomura, M., et al. (2003). Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells. Anticancer Res 23:4781–4787.
  • Tammur, J., Prades, C., Arnould, I., Rzhetsky, A., Hutchinson, A., Adachi, M., et al. (2001). Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene 273:89–96.
  • Tanaka, T., Uchiumi, T., Hinoshita, E., Inokuchi, A., Toh, S., Wada, M., et al. (1999). The human multidrug resistance protein 2 gene: functional characterization of the 5′-flanking region and expression in hepatic cells. Hepatology 30:1507–1512.
  • Tanaka, Y., Aleksunes, L. M., Cui, Y. J., Klaassen, C. D. (2009). ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling. Toxicol Sci 108:247–257.
  • Tanaka, Y., Chen, C., Maher, J. M., Klaassen, C. D. (2008). Ischemia-reperfusion of rat livers decreases liver and increases kidney multidrug resistance associated protein 2 (Mrp2). Toxicol Sci 101:171–178.
  • Tang, W., Yi, C., Kalitsky, J., Piquette-Miller, M. (2000). Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats. Mol Cell Biol Res Commun 4:90–97.
  • Taniguchi, K., Wada, M., Kohno, K., Nakamura, T., Kawabe, T., Kawakami, M., et al. (1996). A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56:4124–4129.
  • Teng, S., Jekerle, V., Piquette-Miller, M. (2003). Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab Dispos 31:1296–1299.
  • Teng, S., Piquette-Miller, M. (2005). The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther 312:841–848.
  • Teng, S., Piquette-Miller, M. (2007). Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis. Br J Pharmacol 151:367–376.
  • Tepsiri, N., Chaturat, L., Sripa, B., Namwat, W., Wongkham, S., Bhudhisawasdi, V., et al. (2005). Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. World J Gastroenterol 11:2748–2753.
  • Tizzano, E. F., Chitayat, D., Buchwald, M. (1993). Cell-specific localization of CFTR mRNA shows developmentally regulated expression in human fetal tissues. Hum Mol Genet 2:219–224.
  • Tomer, G., Ananthanarayanan, M., Weymann, A., Balasubramanian, N., Suchy, F. J. (2003). Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Pediatr Res 53:288–294.
  • Toyoda, Y., Hagiya, Y., Adachi, T., Hoshijima, K., Kuo, M. T., Ishikawa, T. (2008). MRP class of human ATP-binding cassette (ABC) transporters: historical background and new research directions. Xenobiotica 38:833–862.
  • Tran-Paterson, R., Davin, D., Krauss, R. D., Rado, T. A., Miller, D. M. (1992). Expression and regulation of the cystic fibrosis gene during rat liver regeneration. Am J Physiol 263:C55–C60.
  • Trauner, M., Arrese, M., Soroka, C. J., Ananthanarayanan, M., Koeppel, T. A., Schlosser, S. F., et al. (1997). The rat canalicular conjugate export pump (Mrp2) is downregulated in intrahepatic and obstructive cholestasis. Gastroenterology 113:255–264.
  • Tzeng, S. J., Chang, W. C., Huang, J. D. (2005). Transcriptional regulation of the rat Mrp3 gene promoter by the specificity protein (Sp) family members and CCAAT/enhancer binding proteins. J Biomed Sci 12:741–761.
  • Uchiumi, T., Hinoshita, E., Haga, S., Nakamura, T., Tanaka, T., Toh, S., et al. (1998). Isolation of a novel human canalicular multispecific organic anion transporter, cMOAT2/MRP3, and its expression in cisplatin-resistant cancer cells with decreased ATP-dependent drug transport. Biochem Biophys Res Commun 252:103–110.
  • Ueyama, J., Nadai, M., Kanazawa, H., Iwase, M., Nakayama, H., Hashimoto, K., et al. (2005). Endotoxin from various Gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters. Eur J Pharmacol 510:127–134.
  • Uno, S., Uraki, M., Ito, A., Shinozaki, Y., Yamada, A., Kawase, A., et al. (2009). Changes in mRNA expression of ABC and SLC transporters in liver and intestines of the adjuvant-induced arthritis rat. Biopharm Drug Dispos 30:49–54.
  • Vander Borght, S., Komuta, M., Libbrecht, L., Katoonizadeh, A., Aerts, R., Dymarkowski, S. et, al. (2008a). Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin. Liver Int 28:1370–1380.
  • Vander Borght, S. van, Pelt, J. van, Malenstein, H., Cassiman, D., Renard, M., Verslype, C. et, al. (2008b). Upregulation of breast cancer resistance protein expression in hepatoblastoma following chemotherapy: A study in patients and in vitro. Hepatol Res 38:1112–1121.
  • Vee, M. L., Lecureur, V., Stieger, B., Fardel, O. (2009). Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos 37:685–693.
  • Villanueva, S. S., Ruiz, M. L., Ghanem, C. I., Luquita, M. G., Catania, V. A., Mottino, A. D. (2008). Hepatic synthesis and urinary elimination of acetaminophen glucuronide are exacerbated in bile duct-ligated rats. Drug Metab Dispos 36:475–480.
  • Villanueva, S. S., Ruiz, M. L., Soroka, C. J., Cai, S. Y., Luquita, M. G., Torres, A. M., et al. (2006). Hepatic and extrahepatic synthesis and disposition of dinitrophenyl-S-glutathione in bile duct-ligated rats. Drug Metab Dispos 34:1301–1309.
  • Vollrath, V., Wielandt, A. M., Iruretagoyena, M., Chianale, J. (2006). Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene. Biochem J 395:599–609.
  • Vos, T. A., Hooiveld, G. J., Koning, H., Childs, S., Meijer, D. K., Moshage, H., et al. (1998). Upregulation of the multidrug resistance genes, Mrp1 and Mdr1b, and downregulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology 28:1637–1644.
  • Vos, T. A., Ros, J. E., Havinga, R., Moshage, H., Kuipers, F., Jansen, P. L., et al. (1999). Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats. Hepatology 29:1833–1839.
  • Vuillaumier, S., Dixmeras, I., Messai, H., Lapoumeroulie, C., Lallemand, D., Gekas, J., et al. (1997). Cross-species characterization of the promoter region of the cystic fibrosis transmembrane conductance regulator gene reveals multiple levels of regulation. Biochem J 327(Pt 3):651–662.
  • Wagner, M., Fickert, P., Zollner, G., Fuchsbichler, A., Silbert, D., Tsybrovskyy, O., et al. (2003). Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125:825–838.
  • Wagner, M., Halilbasic, E., Marschall, H. U., Zollner, G., Fickert, P., Langner, C., et al. (2005). CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology 42:420–430.
  • Wagner, M., Zollner, G., Fickert, P., Gumhold, J., Silbert, D., Fuchsbichler, A., et al. (2007). Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress. Drug Metab Dispos 35:1694–1699.
  • Wakamatsu, T., Nakahashi, Y., Hachimine, D., Seki, T., Okazaki, K. (2007). The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins. Int J Oncol 31:1465–1472.
  • Wang, Q., Beck, W. T. (1998). Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. Cancer Res 58:5762–5769.
  • Wang, S., Hartley, D. P., Ciccotto, S. L., Vincent, S. H., Franklin, R. B., Kim, M. S. (2003). Induction of hepatic phase II drug-metabolizing enzymes by 1,7-phenanthroline in rats is accompanied by induction of MRP3. Drug Metab Dispos 31:773–775.
  • Wang, T., Ma, X., Krausz, K. W., Idle, J. R., Gonzalez, F. J. (2008). Role of pregnane X receptor in control of all-trans retinoic acid (ATRA) metabolism and its potential contribution to ATRA resistance. J Pharmacol Exp Ther 324:674–684.
  • Watanabe, S., Yokoyama, Y., Oda, K., Kokuryo, T., Shoda, J., Okada, K., et al. (2009). Choleretic effect of inchinkoto, a herbal medicine, on livers of patients with biliary obstruction due to bile duct carcinoma. Hepatol Res 39:247–255.
  • Wielandt, A. M., Vollrath, V., Manzano, M., Miranda, S., Accatino, L., Chianale, J. (1999). Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver. Biochem J 341(Pt 1):105–111.
  • Wortham, M., Czerwinski, M., He, L., Parkinson, A., Wan, Y. J. (2007). Expression of constitutive androstane receptor, hepatic nuclear factor 4 alpha, and P450 oxidoreductase genes determines interindividual variability in basal expression and activity of a broad scope of xenobiotic metabolism genes in the human liver. Drug Metab Dispos 35:1700–1710.
  • Xiong, H., Yoshinari, K., Brouwer, K. L., Negishi, M. (2002). Role of constitutive androstane receptor in the in vivo induction of Mrp3 and CYP2B1/2 by phenobarbital. Drug Metab Dispos 30:918–923.
  • Yabuuchi, H., Shimizu, H., Takayanagi, S., Ishikawa, T. (2001). Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. Biochem Biophys Res Commun 288:933–939.
  • Yabuuchi, H., Takayanagi, S., Yoshinaga, K., Taniguchi, N., Aburatani, H., Ishikawa, T. (2002). ABCC13, an unusual truncated ABC transporter, is highly expressed in fetal human liver. Biochem Biophys Res Commun 299:410–417.
  • Yeh, C. T., Yen, G. C. (2006). Induction of hepatic antioxidant enzymes by phenolic acids in rats is accompanied by increased levels of multidrug resistance-associated protein 3 mRNA expression. J Nutr 136:11–15.
  • Young, S. C., Wang, C. J., Hsu, J. D., Hsu, J. L., Chou, F. P. (2006). Increased sensitivity of Hep G2 cells toward the cytotoxicity of cisplatin by the treatment of piper betel leaf extract. Arch Toxicol 80:319–327.
  • Yu, Q. Y., Shu, M., Dai, J. H., Ma, J. B., Yu, Y., Liu, D. H. (2007a). [The mechanism of the increase of plasma bilirubin after hepatic ischemia-reperfusion in rats]. Zhonghua Gan Zang Bing Za Zhi 15:763–766.
  • Yu, X. Q., Xue, C. C., Wang, G., Zhou, S. F. (2007b). Multidrug resistance-associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs. Curr Drug Metab 8:787–802.
  • Zaman, G. J., Versantvoort, C. H., Smit, J. J., Eijdems, E. W., de Haas, M., Smith, A. J., et al. (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 53:1747–1750.
  • Zhang, F., Chen, X. P., Jing, K., Zhang, W., Li, G. P., Dong, H. H., et al. (2007a). [Expressions of ATP-binding cassette transporter genes in rat hepatic oval cells]. Zhonghua Gan Zang Bing Za Zhi 15:529–533.
  • Zhang, L., Fang, C. H., Fan, Y. F. (2008). [Detection of multidrug resistance-associated proteins MRP2, MRP3, and MRP5 mRNA expressions in hepatocarcinoma cells using SYBR real-time PCR]. Nan Fang Yi Ke Da Xue Xue Bao 28:219–221.
  • Zhang, Y., Li, W., Vore, M. (2007b). Translational regulation of rat multidrug resistance-associated protein 2 expression is mediated by upstream open reading frames in the 5′ untranslated region. Mol Pharmacol 71:377–383.
  • Zhou, S. F., Wang, L. L., Di, Y. M., Xue, C. C., Duan, W., Li, C. G., et al. (2008). Substrates and inhibitors of human multidrug resistance-associated proteins and the implications in drug development. Curr Med Chem 15:1981–2039.
  • Zhu, H., Chen, X. P., Luo, S. F., Guan, J., Zhang, W. G., Zhang, B. X. (2005). Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells. J Exp Clin Cancer Res 24:565–574.
  • Zhu, H., Chen, X. P., Luo, S. F., Guan, J., Zhang, W. G., Zhang, B. X., et al. (2007). [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma]. Zhonghua Wai Ke Za Zhi 45:917–920.
  • Zhu, Q., Center, M. S. (1994). Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin. Cancer Res 54:4488–4492.
  • Zhu, Q., Center, M. S. (1996). Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene. DNA Cell Biol 15:105–111.
  • Zinchuk, V., Zinchuk, O., Akimaru, K., Moriya, F., Okada, T. (2007). Ethanol consumption alters expression and colocalization of bile salt export pump and multidrug resistance protein 2 in the rat. Histochem Cell Biol 127:503–512.
  • Zinchuk, V. S., Okada, T., Akimaru, K., Seguchi, H. (2002). Asynchronous expression and colocalization of Bsep and Mrp2 during development of rat liver. Am J Physiol Gastrointest Liver Physiol 282:G540–G548.
  • Zollner, G, Fickert, P, Fuchsbichler, A, Silbert, D, Wagner, M, Arbeiter, S, et al. (2003a). Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. J Hepatol 39:480–488.
  • Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H. U., Zatloukal, K., et al. (2003b). Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol 38:717–727.
  • Zollner, G., Fickert, P., Zenz, R., Fuchsbichler, A., Stumptner, C., Kenner, L., et al. (2001). Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology 33:633–646.
  • Zollner, G., Wagner, M., Fickert, P., Silbert, D., Fuchsbichler, A., Zatloukal, K., et al. (2005). Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int 25:367–379.
  • Zollner, G., Wagner, M., Fickert, P., Silbert, D., Gumhold, J., Zatloukal, K., et al. (2007). Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Liver Int 27:920–929.
  • Zollner, G., Wagner, M., Moustafa, T., Fickert, P., Silbert, D., Gumhold, J., et al. (2006). Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids. Am J Physiol Gastrointest Liver Physiol 290:G923–G932.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.